Contents
- C-1. Introduction
- C-2. Drug Use Compendia
-
C-3. Drug Use Criteria
- C-3.1. Acetylcholinesterase Inhibitors
- C-3.2. Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs
- C-3.3. Aerosolized Agents - metered-dose inhalers: anti-inflammatory drugs
- C-3.4. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting)
- C-3.5. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting)
- C-3.6. Angiotensin-Converting Enzyme Inhibitors
- C-3.7. Angiotensin II Receptor Blockers
- C-3.8. Anti-depressants, oral (other)
- C-3.9. Anti-depressants, selective serotonin reuptake inhibitors
- C-3.10. Anti-diabetic Agents (oral)
- C-3.11. Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
- C-3.12. Atypical Anti-psychotics (long-acting injectable)
- C-3.13. Atypical Anti-psychotics (oral)
- C-3.14. Benzodiazepines (oral, rectal)
- C-3.15. Complement Inhibitor and Enzyme/Protein Replacement Therapy
- C-3.16. Cyclooxygenase-2 Inhibitors
- C-3.17. Direct Oral Anticoagulants
- C-3.18. Exogenous Insulin Products
- C-3.19. Fentanyl
- C-3.20. Fluoroquinolones (oral)
- C-3.21. Gabapentin
- C-3.22. Glucagon-like Peptide 1 Receptor Agonists
- C-3.23. Histamine H2 - Receptor Antagonists
- C-3.24. Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors
- C-3.25. Hydrocodone Bitartrate/Hydrocodone Polistirex
- C-3.26. Immune Globulins
- C-3.27. Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi)
- C-3.28. Ketorolac (oral)
- C-3.29. Leukotriene Receptor Antagonists
- C-3.30. Low Molecular - Weight Heparins
- C-3.31. Mecasermin
- C-3.32. Memantine
- C-3.33. Nebulized Bronchodilators
- C-3.34. Nitazoxanide (Alinia®)
- C-3.35. Non-sedating Antihistamines
- C-3.36. Non-steroidal anti-inflammatory drugs
- C-3.37. Platelet Aggregation Inhibitors
- C-3.38. Pramlintide
- C-3.39. Promethazine Use In Children Less Than 2 Years of Age
- C-3.40. Proton Pump Inhibitors
- C-3.41. Quetiapine (low dose)
- C-3.42. Rifaximin (Xifaxan)
- C-3.43. Sedative/Hypnotics
- C-3.44. Serotonin 5-HT1B/1D Receptor Agonists
- C-3.45. Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (oral)
- C-3.46. Sickle Cell Disease Products
- C-3.47. Skeletal Muscle Relaxants
- C-3.48. Substance P/Neurokinin1 Receptor Antagonists
- C-3.49. Topical Calcineurin Inhibitors
- C-3.50. Tramadol